Form D — Ovelle Bio Corp.
0002139798-26-000001 · filed Jun 10, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $9,200,000
- Reported amount sold
- $7,000,000
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Ovelle Bio Corp.
- CIK
- 2139798
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 850 NEW BURTON ROAD SUITE 201
DOVER, DE 19904 - Phone
- 800-483-1140
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Travis Carleton Potter · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Merrick Pierson Smela · Executive OfficerBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗